Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions. The Company's tools can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines.
Latest funding size
Time since last funding
|about 2 years|
|Grand Challenges Canada, OS Fund, Khosla Ventures, Draper Associates, Data Collective, Farzad (Zod) Nazem, AME Cloud Ventures, Y Combinator, Draper Fisher Jurvetson (DFJ), Mission and Market|